1-9 of 9
Riccardo Candido
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

When Does Metabolic Memory Start? Insights From the Association of Medical Diabetologists Annals Initiative on Stringent HbA1c Targets

Giuseppina T. Russo, Antonio Nicolucci, Giuseppe Lucisano, Maria Chiara Rossi, Antonio Ceriello, Francesco Prattichizzo, Valeria Manicardi, Alberto Rocca, Paolo Di Bartolo, Salvatore De Cosmo, Graziano Di Cianni, Riccardo Candido
Journal: Diabetes
Diabetes 2024;74(1):75–81
https://doi.org/10.2337/db24-0166
Published: 17 October 2024
View article titled, When Does Metabolic Memory Start? Insights From the Association of Medical Diabetologists Annals Initiative on Stringent HbA<sub>1c</sub> Targets
Open the PDF for When Does Metabolic Memory Start? Insights From the Association of Medical Diabetologists Annals Initiative on Stringent HbA<sub>1c</sub> Targets in another window
Meeting Abstracts

1804-PUB: Switching from Glucagon-Like Peptide-1 Receptor Agonists Therapy to Second Generation Basal Insulins—Comparative Effectiveness Analysis of Glargine 300 U/mL vs. Degludec 100 U/mL—The RESTORE-G Real-World Study

RICCARDO CANDIDO, ANTONIO NICOLUCCI, MONICA LAROSA, MARIA CHIARA ROSSI, RAFFAELE NAPOLI, RESTORE-G STUDY GROUP
Journal: Diabetes
Diabetes 2023;72(Supplement_1):1804-PUB
https://doi.org/10.2337/db23-1804-PUB
Published: 23 June 2023
View article titled, 1804-PUB: Switching from Glucagon-Like Peptide-1 Receptor Agonists Therapy to Second Generation Basal Insulins—Comparative Effectiveness Analysis of Glargine 300 U/mL vs. Degludec 100 U/mL—The RESTORE-G Real-World Study
Meeting Abstracts

84-LB: Intensification of Glucagon-Like Peptide-1 Receptor Agonists Therapy with Glargine 300 U/mL or IDegLira—The RESTORE-G Real-World Study

RICCARDO CANDIDO, ANTONIO NICOLUCCI, MARIA CHIARA ROSSI, MONICA LAROSA, RAFFAELE NAPOLI, RESTORE-G STUDY GROUP
Journal: Diabetes
Diabetes 2023;72(Supplement_1):84-LB
https://doi.org/10.2337/db23-84-LB
Published: 20 June 2023
View article titled, 84-LB: Intensification of Glucagon-Like Peptide-1 Receptor Agonists Therapy with Glargine 300 U/mL or IDegLira—The RESTORE-G Real-World Study
Meeting Abstracts

779-P: Intensification of Glucagon-Like Peptide-1 Receptor Agonists Therapy with First and Second Generation Basal Insulins—The RESTORE-G Real-World Study

RAFFAELE NAPOLI, MONICA LAROSA, ANTONIO NICOLUCCI, MARIA CHIARA ROSSI, RICCARDO CANDIDO, RESTORE-G STUDY GROUP
Journal: Diabetes
Diabetes 2023;72(Supplement_1):779-P
https://doi.org/10.2337/db23-779-P
Published: 20 June 2023
View article titled, 779-P: Intensification of Glucagon-Like Peptide-1 Receptor Agonists Therapy with First and Second Generation Basal Insulins—The RESTORE-G Real-World Study
Meeting Abstracts

87-LB: Treatment Intensification after Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes—The RESTORE-G Real-World Study

RICCARDO CANDIDO, ANTONIO NICOLUCCI, MONICA LAROSA, MARIA CHIARA ROSSI, RAFFAELE NAPOLI, RESTORE-G STUDY GROUP
Journal: Diabetes
Diabetes 2022;71(Supplement_1):87-LB
https://doi.org/10.2337/db22-87-LB
Published: 01 June 2022
View article titled, 87-LB: Treatment Intensification after Glucagon-Like Peptide-1 Receptor Agonists Therapy in Type 2 Diabetes—The RESTORE-G Real-World Study
Meeting Abstracts

110-LB: Efficacy, Safety, and Appropriateness of iGlarLixi, a Fixed-Ratio Combination (FRC) in Type 2 Diabetes (T2D) in Real-World Settings: Results from the ENSURE Study

RICCARDO CANDIDO, MONICA MODUGNO, ENRICO GABELLIERI, ANTONIO NICOLUCCI, MARIA CHIARA ROSSI, MONICA LAROSA, ON BEHALF OF ENSURE STUDY GROUP
Journal: Diabetes
Diabetes 2021;70(Supplement_1):110-LB
https://doi.org/10.2337/db21-110-LB
Published: 01 June 2021
View article titled, 110-LB: Efficacy, Safety, and Appropriateness of iGlarLixi, a Fixed-Ratio Combination (FRC) in Type 2 Diabetes (T2D) in Real-World Settings: Results from the ENSURE Study
Journal Articles

Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis

Josephine M. Forbes, Louis Teo Loon Yee, Vicki Thallas, Markus Lassila, Riccardo Candido, Karin A. Jandeleit-Dahm, Merlin C. Thomas, Wendy C. Burns, Elizabeth K. Deemer, Susan R. Thorpe, Mark E. Cooper, Terri J. Allen
Journal: Diabetes
Diabetes 2004;53(7):1813–1823
https://doi.org/10.2337/diabetes.53.7.1813
Published: 01 July 2004
View article titled, Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis
Open the PDF for Advanced Glycation End Product Interventions Reduce Diabetes-Accelerated Atherosclerosis in another window
Journal Articles

Improved Islet Morphology after Blockade of the Renin- Angiotensin System in the ZDF Rat

Christos Tikellis, Peter J. Wookey, Riccardo Candido, Sof Andrikopoulos, Merlin C. Thomas, Mark E. Cooper
Journal: Diabetes
Diabetes 2004;53(4):989–997
https://doi.org/10.2337/diabetes.53.4.989
Published: 01 April 2004
View article titled, Improved Islet Morphology after Blockade of the Renin- Angiotensin System in the ZDF Rat
Open the PDF for Improved Islet Morphology after Blockade of the Renin- Angiotensin System in the ZDF Rat in another window
Journal Articles

Modulation of Incipient Glomerular Lesions in Experimental Diabetic Nephropathy by Hypotensive and Subhypotensive Dosages of an ACE Inhibitor

Bruno Fabris, Riccardo Candido, Michele Carraro, Francesco Fior, Mary Artero, Cristina Zennaro, Maria Rosa Cattin, Angela Fiorotto, Monica Bortoletto, Cristina Millevoi, Moreno Bardelli, Luigi Faccini, Renzo Carretta
Journal: Diabetes
Diabetes 2001;50(11):2619–2624
https://doi.org/10.2337/diabetes.50.11.2619
Published: 01 November 2001
View article titled, Modulation of Incipient Glomerular Lesions in Experimental Diabetic Nephropathy by Hypotensive and Subhypotensive Dosages of an ACE Inhibitor
Open the PDF for Modulation of Incipient Glomerular Lesions in Experimental Diabetic Nephropathy by Hypotensive and Subhypotensive Dosages of an ACE Inhibitor in another window